Table 2.

COVID-19 and its management details

No	AUTHOR	ICU Admission	Disease severity	Management	Patients received steroids	Dose of steroid (of prednisolone equivalents)*	Mean Duration of Steroid Administration (days)**	Route of steroid administration
1	Agarwala et al. [19]	Yes (1 patient)	NR	Steroids in all patients + ( IV remedesivir + IV tocilizumab in one Patient, and oral favipiravir in another)	Yes	758 mg (400–1250)	22.5 ( reported for two patients out of the three)	( 2 patients IV then oral, 1 patient oral from the start)
2	Sulewski et al. [15]	NR	1 severe, 1 moderate, 1 mild	-Details were not reported -None of the three patients received steroids	No	NA	NA	NA
3	Yilmam et al. [29]	Yes	NR	Steroids, anti-virals, anti-biotics, and anticoagulants	Yes	NR	45	Oral then IV
4	Agarwala et al. [18]	NR	NR	Details were not reported	Yes	841.3 mg (100–3520)	NR	NR
5	Annam et al. [20]	NR	NR	Steroids, anti-virals, and anti-biotics	Yes	1470 ± 305 mg (430 – 1040)	19 (17–21)	Oral & IV
6	Ardakani et al. [21]	NR	NR	Steroids, anti-viral, biologics, and antibiotics	Yes	1695.2 mg (1375–2010)	16 (10–32)	Oral & IV
7	Dhanasekararaja et al. [22]	NR	NR	Details were not reported	Yes	811 mg (200–2100)	19.6 (7–28)	NR
8	Etta et al. [30]	NR	NR	Steroids, anti-virals, and anticoagulants	Yes	NR	NR	NR
9	Jain and Sawant [23]	NR	NR	Steroids, anti-viral, biologics, anti-biotics, and anticoagulants	Yes	NR	22	IV then oral
10	Kamani et al. [24]	yes	NR	Details were not reported	Yes	NR	NR	IV
11	Kandari et al. [25]	Yes (1 patient)	Moderate and severe	steroids and anti-virals	Yes	1855.6 mg (1600–2400)	22	NR
12	Kinjima et al. [26]	Yes	NR	Details were not reported	Yes	NR	NR	NR
13	Maharjan et al. [27]	NR	NR	Details were not reported	Yes	NR	42	Oral and IV
14	Mahran et al. [28]	Yes (1 patient)	1 severe, 3 moderates	Details were not reported	Yes	NR	14.7 (10–14)	NR

*Mean ± SD (range), **Mean (range)

NR not reported, NA not applicable, IV intravenous, mg Milligrams